October 19, 2026 at 08:39 PM UTC
Mineralys Therapeutics, Inc. reports leadership or board changes
Mineralys Therapeutics, Inc. filed an 8-K covering director or executive-officer changes. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.
Official source: U.S. Securities and Exchange Commission
Official source published: October 19, 2026 at 08:37 PM UTC
Open official source